Forudine

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Forudine

Quick Facts

Property Description
Active ingredient Fusidic Acid (or Sodium Fusidate)
Form Cream, Ointment, Tablets, Suspension, Injection
Pharmacological class Antibiotic (Fusidane Class, Bacteriostatic)
Common use Bacterial infections (particularly Staphylococcus species)
Origin Naturally occurring, derived from Fusidium coccineum

What is Forudine and Its Core Classification?

Forudine is a medicinal preparation that contains the active pharmaceutical ingredient Fusidic Acid (or Sodium Fusidate), classifying it as an antimicrobial agent used primarily to manage bacterial infections. This compound belongs to a unique structural class known as the fusidane class of antibiotics. Its use occurs in cases where other antimicrobial treatments are ineffective.

Fusidic Acid is notable because it is a naturally occurring steroidal compound, originally derived from the fungus Fusidium coccineum. This unique origin and chemical arrangement mean that Forudine is clinically recognized as an important therapeutic option, particularly against susceptible strains of Gram-positive bacteria, most notably various Staphylococcus species. Forudine is typically a prescription-only (Rx) medication, distinguishing it from over-the-counter antimicrobial preparations.

What Forms of Forudine Are Available, and What Is Their Purpose?

Forudine is manufactured in several distinct dosage forms, reflecting its broad clinical utility and different routes of administration. These preparations commonly include topical forms, such as cream and ointment, designed for localized application, as well as oral forms, including tablets and suspension, intended for systemic effect throughout the body. The fundamental purpose of all Forudine preparations is to neutralize and halt the progression of bacterial growth. The availability of these multiple forms allows for targeted treatment; for example, the oral suspension form is often positioned specifically for pediatric patient groups, ensuring appropriate administration in children.

What side effects are possible with Forudine?

Possible Side Effects and Safety Information

Official regulatory documentation classifies the possible adverse reactions of Forudine (Fusidic Acid/Sodium Fusidate) based on the route of administration, grouping them into frequency bands such as Common, Uncommon, and Rare, and organizing them by affected system-organ classes.

Documented Adverse Reactions

The safety profile is largely defined by the preparation used. Topical formulations are primarily associated with local skin reactions, while systemic formulations (oral/injection) carry a different range of effects, particularly affecting the gastrointestinal system.

Classification System-Organ Class Focus Examples (Label-Documented)
Common (Systemic) Gastrointestinal Disorders Vomiting, Diarrhoea
Uncommon (Topical/Systemic) Skin and Subcutaneous Tissue Disorders Pruritus, various forms of Rash, Application site pain/irritation
Rare (Topical/Systemic) Immune System Disorders / Eye Disorders Angioedema, Conjunctivitis

Serious Safety Considerations

The label documents specific serious adverse reactions, although these are typically classified as Uncommon or Rare. These include severe hypersensitivity events, such as anaphylactic shock, and potentially serious cutaneous reactions like Stevens-Johnson syndrome (SJS), Toxic Epidermal Necrolysis (TEN), and DRESS. Furthermore, systemic use is associated with Hepatobiliary Disorders, including documented cases of hepatic failure and elevated liver enzymes.

Population and Duration-Related Safety Patterns

Official safety statements note required caution for specific groups. Monitoring of liver function is often listed as necessary for patients with hepatic impairment or those on prolonged systemic therapy. Forudine's systemic use in neonates includes a note on the theoretical risk of kernicterus. Regulatory text also indicates that extended or recurrent use of the topical form may increase the risk of developing antibiotic resistance and local contact sensitisation.

Overdose and Emergency Response

Overdose and when to seek help

This section outlines the officially documented clinical manifestations and required emergency actions for an overdose of Forudine (Fusidic Acid/Sodium Fusidate), as stated in government regulatory documents.

Overdose of the systemic forms (oral or intravenous) is primarily documented by the manifestation of gastrointestinal disturbances. Regulatory files report high-dose, prolonged exposures without resulting in adverse events, suggesting a generally non-severe clinical outcome profile. For topical preparations (cream or ointment), the official regulatory position states that overdose is unlikely to occur.

When to Seek Immediate Help:

Regulators uniformly mandate that individuals must seek immediate medical attention upon suspected or known overdose or accidental ingestion of harmful quantities. Management is explicitly stated to be symptomatic and supportive, directed toward the alleviation of clinical signs. This approach is necessary because official information confirms that dialysis will not increase the clearance of fusidic acid.

A specific population note addresses the accidental ingestion of the topical preparation by children aged less than 1 year and weighing le 10 kg, where consuming a whole tube may exceed the approved systemic daily dose. Immediate medical assessment is required in all such situations.

Therapeutic Uses of Forudine

What Forudine Treats: Main Uses and Benefits

Forudine (Fusidic Acid/Sodium Fusidate) is commonly used to help with symptoms related to specific bacterial infections. Its benefit is generally realized in clinical settings marked by the heightened distress and discomfort stemming from bacterial colonization.


Symptom Management and Key Scenarios

The medication is generally considered relevant in conditions presenting with disruptive symptom manifestations of localized infection, such as impetigo and folliculitis, infected cuts and abrasions, and secondary infections complicating chronic skin issues like eczema. It is applied to ease challenging symptoms like pronounced redness, swelling, pain, and the formation of weeping, yellowish crusts on the skin. This short-term symptomatic assistance is commonly used to help address groups of symptoms that may appear suddenly, providing support that contributes to easing the overall symptom load.

In systemic forms, Forudine is applied in addressing symptoms of deep, acute infections, including osteomyelitis (bone infection) and staphylococcal bacteremia. This is relevant when symptoms are due to organisms like MRSA. It is applied in clinical settings marked by heightened systemic burden.

“Forudine is generally used to help manage the symptomatic discomfort that arises when susceptible bacterial activity overwhelms the skin or tissue.”


Quick Facts & Therapeutic Focus

Property Description
Quick Fact: Relief for Localized Pain and Inflammation related to bacterial skin infections.
Therapeutic Scope Supports symptomatic relief in Dermatology, Ophthalmology, and systemic Infectious Disease contexts.
Benefit Focus Helps maintain a sense of stability and supports general well-being during symptomatic phases.

Eligibility and Restrictions for Use

The official population eligibility profile for Forudine (Fusidic Acid/Sodium Fusidate) is defined by mandatory exclusions and conditional use guidelines documented in regulatory prescribing information.

Category Official Regulatory Statement
Allowed Populations Adults and Children are standard populations for both topical and systemic forms. No special adjustments are required for the Geriatric population (older adults) for topical use.
Contraindicated Populations Individuals with known Hypersensitivity to fusidic acid/sodium fusidate or any excipients. Must not be used for infections caused by non-susceptible bacteria, such as P. aeruginosa.
Condition-Specific Rules Systemic use requires caution and monitoring in patients with hepatic dysfunction (liver disease). Oral tablet forms are prohibited for patients with specific hereditary sugar intolerances (e.g., lactase deficiency) due to excipient content.
Pregnancy and Lactation Topical use is permitted during pregnancy (due to negligible systemic exposure) and lactation. Application to the breast area must be avoided while breastfeeding.
Age-Related Restrictions Systemic use requires particular care in neonates due to the theoretical risk of kernicterus.

The regulatory profile imposes absolute contraindications for allergy and non-susceptible pathogens. Use is conditionally restricted for the systemic formulation in patients with impaired liver function and neonates, emphasizing that eligibility is context-dependent based on the formulation and the patient's physiological status.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents define specific restrictions for the co-administration of systemic Forudine (Fusidic Acid/Sodium Fusidate), as topical forms present minimal risk due to negligible systemic absorption.

Formal Restrictions and Contraindications

Classification Interacting Substance Official Regulatory Outcome
Contraindicated Combination Statins (HMG-CoA reductase inhibitors), e.g., Simvastatin, Atorvastatin Prohibited co-administration due to the risk of severe, potentially fatal rhabdomyolysis. Statin therapy must be discontinued.
Not Recommended Co-use HIV Protease Inhibitors (e.g., Ritonavir, Saquinavir) May lead to increased plasma concentrations of both agents via a pharmacokinetic interaction, carrying a risk of hepatotoxicity.

Exposure and Effect Alteration

Co-administration with oral anticoagulants (Coumarin derivatives) may officially alter the anticoagulant effect and necessitate close monitoring. Furthermore, Fusidic Acid exhibits a binding interaction by competitively inhibiting the binding of bilirubin to albumin.

Timing and Population Cautions

The official profile mandates a specific timing separation: statin therapy may only be re-introduced seven days after the last dose of systemic Forudine. Neonates require particular care due to the documented bilirubin binding inhibition, which carries a theoretical risk of kernicterus. Caution and monitoring of liver function are required for patients with hepatic dysfunction.

Mechanism of Action

Forudine, containing the active substance fusidic acid, exerts its pharmacodynamic effect by specifically targeting the bacterial protein synthesis apparatus. The drug, a member of the fusidane class of antibiotics, functions as a bacteriostatic inhibitor. Its primary molecular target is the elongation factor G (EF-G), a protein essential for the translocation step on the bacterial 70S ribosome.

Fusidic acid binds to EF-G when it is associated with the GTP-bound 70S ribosome. This binding event sterically inhibits the dissociation of the EF-G-GDP complex from the ribosome following GTP hydrolysis. The resultant stable complex effectively arrests the elongation cycle of peptide chain synthesis. The intracellular consequence is the cessation of crucial protein production, leading to a system-level inhibition of bacterial proliferation.

Dosage and Administration Information

How Forudine (Fusidic Acid) is Used

Forudine is administered through distinct routes depending on the clinical scenario: topical, oral, and intravenous (IV) infusion. This selection is governed entirely by the specific dosage form and therapeutic intent, distinguishing localized from systemic use.


Official Administration Routes and Dosing Patterns

The dosage and frequency are standardized according to established protocols. The total daily dose is divided to ensure consistent presence of the antibiotic.

Administration Scope Official Dosing Principles
Route of Administration Topical, Oral (Tablets/Suspension), or Intravenous (IV).
Adult Systemic Dosing Generally 500 mg taken twice daily (oral) or administered three times daily (IV).
Topical Dosing Applied to the affected area two to three times daily.

Administration Conditions and Course Duration

Systemic use (oral and IV) requires adherence to specific administration conditions. The IV formulation is supplied as a powder and must undergo reconstitution and subsequent dilution in an approved solution before infusion. This slow intravenous administration is required to minimize irritation and is typically delivered over a period of at least two hours per dose. Oral doses can generally be taken with or without food.

Pediatric dosing for the oral suspension is determined based on body weight (mg/kg) and is administered in divided daily doses. For all forms, treatment involves a fixed course length; the topical course is typically short-term (7 to 14 days), while systemic duration varies but must be completed as prescribed, regardless of early resolution. If a dose is missed, standard protocols suggest taking it as soon as remembered, unless it is close to the time for the next scheduled dose, in which case the missed dose should be skipped.

Recent Clinical Evidence

Research evidence / Overview of studies for Forudine

Evidence for Use in Localized Bacterial Skin Infections (e.g., Impetigo)

Forudine was studied for short-term use in impetigo. Studies explored the compound's profile by conducting short-term Randomized Controlled Trials (RCTs), where patients were often compared against a non-treatment (placebo) or other available topical antibiotics. These studies were evaluated in populations primarily consisting of systemically healthy children and adolescents who presented with limited and uncomplicated lesions.

The research highlights changes measured during the study period related to observable outcomes, such as the healing of scabs, pus, and inflammation. Findings describe patterns observed in the studies related to clinical response metrics and the microbial clearance rates. This evidence contributes to understanding symptom patterns over the short intervals defined by the trials.

Evidence for Secondary and Other Skin and Soft-Tissue Infections

Research also examined Forudine in studies exploring a broader range of skin and soft-tissue infections, including conditions characterized by fluctuating or episodic manifestations, such as folliculitis and secondarily infected dermatoses like eczema. These studies monitored outcomes related to physical discomfort. The evidence for these conditions has been compiled but often confined to infections that are limited or localized in area. Research documents the emergence of resistance among bacterial isolates, especially in populations with chronic skin conditions, suggesting this is a factor that research is ongoing to fully characterize.

What is Still Uncertain About Forudine Research

Evidence quality varies across studies, with many older RCTs noted as having structures that introduced methodological uncertainties. Comparative evidence is lacking for many specific regimens, and data for certain groups are insufficient. Long-term effects are not fully established across the general population of patients who use Forudine for common skin infections.

Frequently Asked Questions (FAQ)

Common questions about Forudine (FAQ)


Q: How long does the drug Forudine stay in your system?

Official documents providing information on how the body handles the medicine (pharmacokinetics) state that fusidic acid is primarily eliminated through a process called biliary excretion. The process involves the drug being primarily processed and eliminated via bile. Very little of the medicine is removed from the body through the urine.


Q: Can Forudine cause changes in sleep patterns?

The official regulatory safety profile for Forudine organizes possible adverse reactions by frequency, such as common, uncommon, and rare effects. Changes in sleep patterns, such as insomnia or drowsiness, are not listed in the documented adverse reactions.


Q: Is there a link between Forudine and weight changes?

According to the official regulatory documents, weight changes are not reported as a documented side effect for the medicine alone. The safety information lists various possible adverse reactions but does not indicate a link with weight gain or weight loss.


Q: Are headaches a common side effect reported for Forudine?

Official regulatory documents listing the adverse reactions associated with Forudine do not list headaches among the documented common, uncommon, or rare effects.


Q: Can Forudine affect blood pressure readings?

The formal safety profile provided by regulatory bodies does not report effects on blood pressure among the documented adverse reactions for Forudine.


Q: Is it possible to take Forudine with common pain relievers like paracetamol?

For the topical forms of Forudine, such as creams and ointments, official patient information indicates that interactions are not typically reported with non-prescription medicines or supplements. This is because the topical application results in negligible absorption into the body.


Q: Does consuming alcohol while using Forudine pose a known interaction risk?

Official patient information for the topical forms of the medication states that consuming alcohol is not known to affect the medicine. The chance of systemic interaction is low due to minimal absorption.


Q: What general advice is given about using Forudine with herbal supplements?

The official patient information for topical Forudine products indicates that problems are not typically reported when using the medicine alongside herbal remedies or supplements. This is generally due to the minimal absorption of the topical form into the bloodstream.


Q: How is Forudine generally processed by the body (metabolism)?

When administered systemically (such as orally or by injection), fusidic acid is extensively metabolized by the body. The resulting breakdown products are predominantly eliminated through biliary excretion, a process where the resulting metabolites are removed from the body via bile.


Q: Does Forudine have any known effects on mental clarity or driving ability?

According to the official product documents, topical application of Forudine is stated to have no or a negligible influence on a person's ability to drive or use machines. This is related to the very low level of the drug that enters the bloodstream after topical use.


Q: Is Forudine a common type of medication in its class?

Scientific literature indicates that the active ingredient, fusidic acid, belongs to a unique structural class of antibiotics called the fusidane class. Fusidic acid is described as the only marketed member of this specific class.


Q: How does the purpose of Forudine differ from other well-known treatments?

The drug's profile is characterized by its unique structure and novel mechanism of action, which is described in official documents. This involves a novel method of inhibiting bacterial protein synthesis, a unique approach described in official documents.


Q: Is Forudine available in different strengths or formulations?

Official product information confirms that Forudine is manufactured in various formulations, which include topical cream and ointment, as well as oral tablets. These forms are also available in different strengths; for example, many topical products are supplied in a 2% concentration.


Q: Are there any ongoing trials or research themes involving Forudine?

Research is continually exploring new ways to optimize the use of fusidic acid. Current research themes include investigating new dosing regimens, such as front-loaded dosing, and developing strategies that could potentially extend the drug's half-life.


Q: Why is Forudine sometimes referred to by its active ingredient name?

Medications are often referred to by their active ingredient, which for this product is fusidic acid (or sodium fusidate). This is because the active ingredient is the specific chemical substance responsible for the therapeutic effect, a common naming practice in medical literature and official communications.


Q: Are there certain types of foods or drinks that should be avoided with Forudine?

Official pharmacokinetics data for the systemic (oral or intravenous) form indicates that taking the medicine with food can decrease the extent of the drug's absorption. For topical applications, no specific food or drink is generally advised against.

How should Forudine be stored and disposed of?

Regulatory documents define mandatory conditions for the storage and disposal of Fusidic Acid preparations. The medicine must be stored in its original package and kept out of the sight and reach of children.

Official Storage Conditions

Requirement Description (Varies by Form)
Temperature Store below 30^circC (or 25^circC for some topical forms).
Protection Keep in a dry and dark place; the cream formulation must not be frozen.
Stability Discard topical products (cream/ointment) within 4 weeks (28 days) or 3 months of first opening the container.

Disposal Instructions

Expired or unused product must not be thrown away in wastewater or household waste. Disposal must be carried out in accordance with local regulatory requirements, and patients should consult a pharmacist regarding the proper method for discarding the medicine.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Forudine found in:

A-Z Index: